Cargando…
Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease
Pain is the highest prioritized patient-reported outcome in people with autosomal dominant polycystic kidney disease (ADPKD) but it remains infrequently and inconsistently measured across countries, studies and trials. The study by El-Damanawi et al. integrated a network of ADPKD expert clinicians,...
Autores principales: | Torra, Roser, Pérez-Gómez, Maria Vanessa, Furlano, Mónica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573017/ https://www.ncbi.nlm.nih.gov/pubmed/34754424 http://dx.doi.org/10.1093/ckj/sfab132 |
Ejemplares similares
-
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013) -
Recent advances in the clinical management of autosomal dominant polycystic kidney disease
por: Torra, Roser
Publicado: (2019) -
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease
por: Naranjo, Javier, et al.
Publicado: (2021) -
Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022) -
Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease Progression
por: Quiroga, Borja, et al.
Publicado: (2022)